Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|August 25, 2015
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including AtherosclerosisYannick Waumans, Lesley Baerts, Kaat Kehoe, et al.
Plos One|November 7, 2015
Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper SamplingLesley Baerts, Yannick Waumans, Inger Brandt, et al.
Analytical Biochemistry|September 17, 2013
Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurementsKaat Kehoe, Robert Verkerk, Yani Sim, et al.
Clinical & Experimental Metastasis|August 3, 2015
Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in miceJae-Hwi Jang, Lesley Baerts, Yannick Waumans, et al.
Basic Research in Cardiology|April 24, 2013
Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosisVeerle Matheeussen, Yannick Waumans, Wim Martinet, et al.
Plos One|September 15, 2021
Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancerTim Muilwijk, Murat Akand, Sofie Daelemans, et al.
Inflammation|October 12, 2015
The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in MiceYannick Waumans, Gwendolyn Vliegen, Lynn Maes, et al.
Seminars in Cancer Biology|January 23, 2018
Histopathological growth patterns as a candidate biomarker for immunomodulatory therapyPieter-Jan van Dam, Sofie Daelemans, Elizabeth Ross, et al.
Biochimie|February 21, 2025
The prolyl oligopeptidase and α-synuclein connection revisitedRoos Van Elzen, Yannick Waumans, Sangeeta Nath, et al.
Plos One|September 2, 2016
Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer TissueKoen M Marien, Valerie Croons, Yannick Waumans, et al.
Pageof 2